Literature DB >> 16338151

On the relation between sensory deafferentation, pain and thalamic activity in Wallenberg's syndrome: a PET-scan study before and after motor cortex stimulation.

Luis Garcia-Larrea1, Joseph Maarrawi, Roland Peyron, Nicolas Costes, Patrick Mertens, Michel Magnin, Bernard Laurent.   

Abstract

Decrease of thalamic blood flow contralateral to neuropathic pain has been described by several groups, but its relation with sensory deafferentation remains unclear. Here we report one instance where the thalamic effects of sensory deafferentation could be dissociated from those of neuropathic pain. A 50-year-old patient underwent a left medullary infarct leading to right-sided thermal and pain hypaesthesia up to the third right trigeminal division, as well as in the left face. During the following months the patient developed neuropathic pain limited to the left side of the face. Although the territory with sensory loss was much wider in the right (non painful) than in the left (painful) side of the body, PET-scan demonstrated significant reduction of blood flow in the right thalamus (contralateral to the small painful area) relative to its homologous region. After 3 months of right motor cortex stimulation the patient reported 60% relief of his left facial pain, and a new PET-scan showed correction of the thalamic asymmetry. We conclude that thalamic PET-scan hypoactivity contralateral to neuropathic pain does not merely reflect deafferentation, but appears related to the pain pathophysiology, and may be normalized in parallel with pain relief. The possible mechanisms linking thalamic hypoactivity and pain are discussed in relation with findings in epileptic patients, possible compensation phenomena and bursting thalamic discharges described in animals and humans. Restoration of thalamic activity in neuropathic pain might represent one important condition to obtain successful relief by analgesic procedures, including cortical neurostimulation.

Entities:  

Mesh:

Year:  2005        PMID: 16338151     DOI: 10.1016/j.ejpain.2005.10.008

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  7 in total

1.  Treatment of a patient with posterior cortical atrophy (PCA) with chiropractic manipulation and Dynamic Neuromuscular Stabilization (DNS): A case report.

Authors:  Vinicius T Francio; Ron Boesch; Michael Tunning
Journal:  J Can Chiropr Assoc       Date:  2015-03

2.  Motor cortex stimulation for facial chronic neuropathic pain: A review of the literature.

Authors:  Guillermo A Monsalve
Journal:  Surg Neurol Int       Date:  2012-10-31

3.  Dynamics of Circadian Thalamocortical Flow of Information during a Peripheral Neuropathic Pain Condition.

Authors:  Helder Cardoso-Cruz; Koichi Sameshima; Deolinda Lima; Vasco Galhardo
Journal:  Front Integr Neurosci       Date:  2011-08-23

4.  Long-term Effect and Predictive Factors of Motor Cortex and Spinal Cord Stimulation for Chronic Neuropathic Pain.

Authors:  Takafumi Tanei; Yasukazu Kajita; Satoshi Maesawa; Daisuke Nakatsubo; Kosuke Aoki; Hiroshi Noda; Shigenori Takebayashi; Norimoto Nakahara; Toshihiko Wakabayashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-08-30       Impact factor: 1.742

5.  Repetitive transcranial magnetic stimulation alone and in combination with motor control exercise for the treatment of individuals with chronic non-specific low back pain (ExTraStim trial): study protocol for a randomised controlled trial.

Authors:  Philippe Patricio; Jean-Sébastien Roy; Luciana Macedo; Mathieu Roy; Guillaume Léonard; Paul Hodges; Hugo Massé-Alarie
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692

Review 6.  Supraspinal Mechanisms Underlying Ocular Pain.

Authors:  Nicholas J Pondelis; Eric A Moulton
Journal:  Front Med (Lausanne)       Date:  2022-02-08

7.  Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in diabetic neuropathic pain.

Authors:  Franco Cauda; Katiuscia Sacco; Federico D'Agata; Sergio Duca; Dario Cocito; Giuliano Geminiani; Filippo Migliorati; Gianluca Isoardo
Journal:  BMC Neurosci       Date:  2009-11-26       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.